| Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana MC Thigpen, PM Kebaabetswe, LA Paxton, DK Smith, CE Rose, ... New England journal of medicine 367 (5), 423-434, 2012 | 2376 | 2012 |
| Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study FJ Palella Jr, RK Baker, AC Moorman, JS Chmiel, KC Wood, JT Brooks, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 43 (1), 27-34, 2006 | 1835 | 2006 |
| Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents JE Kaplan, C Benson, KK Holmes, JT Brooks, A Pau, H Masur, ... MMWR Recomm Rep 58 (4), 1-207, 2009 | 1764 | 2009 |
| Effect of early versus deferred antiretroviral therapy for HIV on survival MM Kitahata, SJ Gange, AG Abraham, B Merriman, MS Saag, AC Justice, ... New England Journal of Medicine 360 (18), 1815-1826, 2009 | 1586 | 2009 |
| Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003 P Patel, DL Hanson, PS Sullivan, RM Novak, AC Moorman, TC Tong, ... Annals of internal medicine 148 (10), 728-736, 2008 | 1089 | 2008 |
| SARS-CoV-2 transmission from people without COVID-19 symptoms MA Johansson, TM Quandelacy, S Kada, PV Prasad, M Steele, JT Brooks, ... JAMA network open 4 (1), e2035057-e2035057, 2021 | 1087 | 2021 |
| Emergence of SARS-CoV-2 b. 1.1. 7 lineage—united states, december 29, 2020–january 12, 2021 SE Galloway MMWR. Morbidity and mortality weekly report 70, 2021 | 776 | 2021 |
| Evidence supporting transmission of severe acute respiratory syndrome coronavirus 2 while presymptomatic or asymptomatic NW Furukawa, JT Brooks, J Sobel Emerging infectious diseases 26 (7), 2020 | 581 | 2020 |
